TABLE 2.

Results of drug sensitivity testing of HSV-1 clinical isolates from patient 708

Patient agea (yrs)	Site of swab	IC50 (μg/ml)b of:		Last recorded therapy
		ACV	Foscarnet
18.84	Skin	13	22	ACV and foscarnet
18.79	Left inguinal area	0.5	14	Foscarnet
14.39	Labium	3.2	19	ACV
14.39	Abdomen	1.9	16	ACV
13.67	Chin	0.1	27	Foscarnet
13.62	Face	0.2	48	Foscarnet
13.10	Vagina	3.9	NR	ACV
13.10	Vagina	1.8	NR	ACV

^aAge at which the corresponding swab sample was taken.

^bResistance is defined as an IC₅₀ of ACV of ≥2 μg/ml and an IC₅₀ of foscarnet of ≥150 μg/ml. NR, not recorded.